Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pi-Sunyer X"" wg kryterium: Autor


Tytuł :
Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability: An Ancillary Study of the Look AHEAD Study.
Autorzy :
Huckfeldt PJ; Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.
Frenier C; Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis.
Pajewski NM; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Espeland M; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Peters A; Keck School of Medicine of the University of Southern California, Los Angeles.
Casanova R; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Pi-Sunyer X; Columbia University, New York, New York.
Cheskin L; George Mason University, Fairfax, Virginia.
Goldman DP; Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.; School of Pharmacy, University of Southern California, Los Angeles.; Price School of Public Policy, University of Southern California, Los Angeles.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2020 Nov 02; Vol. 3 (11), pp. e2025488. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Life Style*
Behavior Therapy/*methods
Diabetes Mellitus, Type 2/*therapy
Diet Therapy/*methods
Exercise Therapy/*methods
Health Care Costs/*statistics & numerical data
Medicare/*economics
Aged ; Body Weight ; Counseling/methods ; Diabetes Mellitus, Type 2/economics ; Diabetes Mellitus, Type 2/metabolism ; Disability Evaluation ; Eligibility Determination ; Emergency Service, Hospital/economics ; Emergency Service, Hospital/statistics & numerical data ; Female ; Glycated Hemoglobin A/metabolism ; Health Expenditures ; Health Services/economics ; Health Services/statistics & numerical data ; Hospitalization/economics ; Hospitalization/statistics & numerical data ; Humans ; Male ; Medicare Part A/economics ; Medicare Part B/economics ; Medicare Part D/economics ; Middle Aged ; United States
Czasopismo naukowe
Tytuł :
Impact of an 8-Year Intensive Lifestyle Intervention on an Index of Multimorbidity.
Autorzy :
Espeland MA; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Gaussoin SA; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Bahnson J; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Vaughan EM; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Knowler WC; Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, USA.
Simpson FR; Department of Mathematics, Winston-Salem State University, Winston-Salem, North Carolina, USA.
Hazuda HP; Department of Clinical Epidemiology, University of Texas Health Science Center, San Antonio, Texas, USA.
Johnson KC; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Munshi MN; Joslin Geriatric Diabetes Program, Joslin Diabetes Center, Boston, Massachusetts, USA.
Coday M; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Pi-Sunyer X; Department of Medicine, Columbia University School of Medicine, New York, New York, USA.
Pokaż więcej
Źródło :
Journal of the American Geriatrics Society [J Am Geriatr Soc] 2020 Oct; Vol. 68 (10), pp. 2249-2256. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Health Status Indicators*
Multimorbidity*
Weight Reduction Programs*
Diabetes Mellitus, Type 2/*therapy
Obesity/*therapy
Aged ; Body Mass Index ; Caloric Restriction ; Chronic Disease/epidemiology ; Chronic Disease/therapy ; Diabetes Mellitus, Type 2/epidemiology ; Diet, Reducing ; Exercise ; Female ; Humans ; Life Style ; Male ; Middle Aged ; Obesity/epidemiology ; Treatment Outcome ; Weight Loss
Czasopismo naukowe
Tytuł :
Do menopausal status and APOE4 genotype alter the long-term effects of intensive lifestyle intervention on cognitive function in women with type 2 diabetes mellitus?
Autorzy :
Yassine HN; Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: .
Anderson A; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Brinton R; Departments of Pharmacology and Neurology, College of Medicine, University of Arizona, Tucson, AZ, USA.
Carmichael O; Pennington Biomedical Research Center, Baton Rouge, LA, USA.
Espeland MA; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Hoscheidt S; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Hugenschmidt CE; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Keller JN; Pennington Biomedical Research Center, Baton Rouge, LA, USA.
Peters A; Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Pi-Sunyer X; Columbia University Medical Center, New York, NY, USA.
Pokaż więcej
Źródło :
Neurobiology of aging [Neurobiol Aging] 2020 Aug; Vol. 92, pp. 61-72. Date of Electronic Publication: 2020 Apr 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Cognition*
Genotype*
Life Style*
Apolipoprotein E4/*genetics
Diabetes Mellitus, Type 2/*genetics
Diabetes Mellitus, Type 2/*psychology
Menopause/*genetics
Menopause/*physiology
Weight Loss/*physiology
Aged ; Female ; Heterozygote ; Humans ; Middle Aged ; Time Factors
Czasopismo naukowe
Tytuł :
Infertility, Gravidity, and Risk Of Diabetes among High-Risk Women in the Diabetes Prevention Program Outcomes Study.
Autorzy :
Kim C; Departments of Medicine, Obstetrics & Gynecology, and Epidemiology, University of Michigan, Ann Arbor, Michigan.
Younes N; Biostatistics Center, George Washington University, Rockville, Maryland.
Temprosa M; Biostatistics Center, George Washington University, Rockville, Maryland.; Department of Epidemiology & Biostatistics, George Washington University, Washington, DC.
Edelstein S; Biostatistics Center, George Washington University, Rockville, Maryland.; Department of Epidemiology & Biostatistics, George Washington University, Washington, DC.
Goldberg RB; Department of Medicine, University of Miami, Miami, Florida.
Araneta MG; Department of Family and Preventive Medicine, University of California, San Diego, California.
Wallia A; Department of Medicine, Northwestern University, Chicago, Illinois.
Brown A; Department of Medicine, Washington University, St. Louis, Missouri.
Darwin C; Department of Medicine, University of California, Los Angeles, California.
Ibebuogu U; Department of Medicine, University of Tennessee, Memphis, Tennessee.
Pi-Sunyer X; Department of Medicine, Columbia University College of Physicians and Surgeons, New York City, New York.
Knowler WC; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Phoenix, Arizona.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Mar 01; Vol. 105 (3).
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Preventive Health Services*/methods
Preventive Health Services*/statistics & numerical data
Diabetes Mellitus, Type 2/*epidemiology
Diabetes Mellitus, Type 2/*etiology
Diabetes Mellitus, Type 2/*prevention & control
Gravidity/*physiology
Infertility, Female/*epidemiology
Adult ; Aged ; Diabetes Mellitus, Type 2/diagnosis ; Female ; Humans ; Incidence ; Infertility, Female/complications ; Life Style ; Metformin/therapeutic use ; Middle Aged ; Pregnancy ; Primary Prevention/methods ; Primary Prevention/organization & administration ; Risk Factors ; Risk Reduction Behavior ; Treatment Outcome ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
Autorzy :
Apolzan JW; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana (J.W.A., K.M.G.).
Venditti EM; Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (E.M.V.).
Edelstein SL; George Washington University Biostatistics Center, Rockville, Maryland (S.L.E.).
Knowler WC; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona (W.C.K.).
Dabelea D; Colorado School of Public Health, Aurora, Colorado (D.D.).
Boyko EJ; Seattle Epidemiologic Research and Information Center, VA Puget Sound Health Care System, Seattle, Washington (E.J.B.).
Pi-Sunyer X; Columbia University College of Physicians and Surgeons, New York, New York (X.P.).
Kalyani RR; Johns Hopkins University School of Medicine, Baltimore, Maryland (R.R.K.).
Franks PW; Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden (P.W.F.).
Srikanthan P; University of California, Los Angeles, Los Angeles, California (P.S.).
Gadde KM; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana (J.W.A., K.M.G.).
Pokaż więcej
Corporate Authors :
Diabetes Prevention Program Research Group
Źródło :
Annals of internal medicine [Ann Intern Med] 2019 May 21; Vol. 170 (10), pp. 682-690. Date of Electronic Publication: 2019 Apr 23.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Video-Audio Media
MeSH Terms :
Life Style*
Diabetes Mellitus, Type 2/*prevention & control
Hypoglycemic Agents/*therapeutic use
Metformin/*therapeutic use
Weight Loss/*drug effects
Female ; Humans ; Male ; Middle Aged ; United States
Czasopismo naukowe
Tytuł :
Changes in body composition and metabolic disease risk.
Autorzy :
Pi-Sunyer X; Columbia University College of Physicians and Surgeons and Columbia Institute of Human Nutrition, New York, NY, USA. .
Pokaż więcej
Źródło :
European journal of clinical nutrition [Eur J Clin Nutr] 2019 Feb; Vol. 73 (2), pp. 231-235. Date of Electronic Publication: 2018 Oct 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Body Composition*
Diabetes Mellitus, Type 2/*physiopathology
Metabolic Syndrome/*physiopathology
Humans
Czasopismo naukowe
Tytuł :
Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
Autorzy :
Pilla SJ; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.
Balasubramanyam A; b Baylor College of Medicine , Houston , TX , USA.
Knowler WC; c National Institute of Diabetes and Digestive and Kidney Diseases , Phoenix , AZ , USA.
Lazo M; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
Nathan DM; e Massachusetts General Hospital and Harvard Medical School , Boston , MA , USA.
Pi-Sunyer X; f Columbia University Medical Center , New York , NY , USA.
Clark JM; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
Maruthur NM; a Department of Medicine, Division of General Internal Medicine , The Johns Hopkins University School of Medicine, Baltimore , MD , USA.; d Department of Epidemiology , The Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.
Pokaż więcej
Corporate Authors :
Look AHEAD Research Group
Źródło :
Autoimmunity [Autoimmunity] 2018 Dec; Vol. 51 (8), pp. 408-416. Date of Electronic Publication: 2019 Jan 02.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms :
Autoantibodies/*blood
Diabetes Mellitus, Type 2/*immunology
Islets of Langerhans/*immunology
Overweight/*immunology
Adiposity/immunology ; Aged ; Autoantibodies/immunology ; Autoantigens/immunology ; Autoantigens/metabolism ; Autoimmunity ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/rehabilitation ; Female ; Healthy Lifestyle ; Humans ; Hypoglycemic Agents/therapeutic use ; Islets of Langerhans/metabolism ; Male ; Middle Aged ; Overweight/blood ; Overweight/rehabilitation ; Patient Education as Topic ; Prospective Studies ; Weight Loss/immunology
Czasopismo naukowe
Tytuł :
Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study.
Autorzy :
Houston DK; Wake Forest School of Medicine, Winston-Salem, North Carolina.
Neiberg RH; Wake Forest School of Medicine, Winston-Salem, North Carolina.
Miller ME; Wake Forest School of Medicine, Winston-Salem, North Carolina.
Hill JO; University of Colorado Denver School of Medicine, Aurora.
Jakicic JM; University of Pittsburgh, Pennsylvania.
Johnson KC; University of Tennessee Health Science Center, Memphis.
Gregg EW; Centers for Disease Control, Atlanta, Georgia.
Hubbard VS; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Pi-Sunyer X; Columbia University Medical Center, New York, New York.
Rejeski WJ; Wake Forest University, Winston-Salem, North Carolina.
Wing RR; Brown University and Miriam Hospital, Providence, Rhode Island.
Bantle JP; University of Minnesota, Minneapolis.
Beale E; Keck School of Medicine of University of Southern California, Los Angeles.
Berkowitz RI; Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Cassidy-Begay M; Southwestern American Indian Center, Phoenix, Arizona.
Clark JM; Johns Hopkins School of Medicine, Baltimore, Maryland.
Coday M; University of Tennessee Health Science Center, Memphis.
Delahanty LM; Massachusetts General Hospital, Boston.
Dutton G; University of Alabama at Birmingham School of Medicine.
Egan C; Weight Control and Diabetes Research Center, Providence, Rhode Island.
Foreyt JP; Baylor College of Medicine, Houston, Texas.
Greenway FL; Pennington Biomedical Research Center, Baton Rouge, Louisiana.
Hazuda HP; University of Texas Health Science Center at San Antonio.
Hergenroeder A; University of Pittsburgh, Pennsylvania.
Horton ES; Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
Jeffery RW; University of Minnesota, Minneapolis.
Kahn SE; University of Washington, Seattle.
Kure A; University of Washington, Seattle.
Knowler WC; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona.
Lewis CE; University of Alabama at Birmingham School of Medicine.
Martin CK; Pennington Biomedical Research Center, Baton Rouge, Louisiana.
Michaels S; Indian Health Service, Shiprock, New Mexico.
Montez MG; University of Texas Health Science Center at San Antonio.
Nathan DM; Massachusetts General Hospital, Boston.
Patricio J; Columbia University Medical Center, New York, New York.
Peters A; Keck School of Medicine of University of Southern California, Los Angeles.
Pownall H; Baylor College of Medicine, Houston, Texas.
Regensteiner J; University of Colorado Denver School of Medicine, Aurora.
Steinburg H; University of Tennessee Health Science Center, Memphis.
Wadden TA; Perelman School of Medicine, University of Pennsylvania, Philadelphia.
White K; Johns Hopkins School of Medicine, Baltimore, Maryland.
Yanovski SZ; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Zhang P; Centers for Disease Control, Atlanta, Georgia.
Kritchevsky SB; Wake Forest School of Medicine, Winston-Salem, North Carolina.
Pokaż więcej
Źródło :
The journals of gerontology. Series A, Biological sciences and medical sciences [J Gerontol A Biol Sci Med Sci] 2018 Oct 08; Vol. 73 (11), pp. 1552-1559.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Life Style*
Diabetes Mellitus, Type 2/*therapy
Aged ; Caloric Restriction ; Diabetes Mellitus, Type 2/epidemiology ; Exercise ; Female ; Hand Strength ; Humans ; Male ; Middle Aged ; Obesity/epidemiology ; Overweight/epidemiology ; Physical Functional Performance ; Walking Speed ; Weight Reduction Programs
Czasopismo naukowe
Tytuł :
Long Term Effect of Intensive Lifestyle Intervention on Cerebral Blood Flow.
Autorzy :
Espeland MA; Department of Biostatistical Sciences, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Luchsinger JA; Department of Medicine, Columbia University Medical Center, New York, New York.
Neiberg RH; Department of Biostatistical Sciences, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Carmichael O; Brain and Metabolism Imaging in Chronic Disease Laboratory and Institute for Dementia Research and Prevention, Pennington Biomedical Research Center, Baton Rouge, Louisiana.
Laurienti PJ; Department of Radiology, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Pi-Sunyer X; Department of Medicine, Columbia University Medical Center, New York, New York.
Wing RR; Department of Psychiatry and Human Behavior, The Miriam Hospital and Alpert School of Medicine at Brown University, Providence, Rhode Island.
Cook D; Department of Biostatistical Sciences, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Horton E; Joslin Diabetes Center, Boston, Massachusetts.
Casanova R; Department of Biostatistical Sciences, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
Erickson K; Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Nick Bryan R; University of Pennsylvania, Philadelphia, Pennsylvania.
Pokaż więcej
Corporate Authors :
Action for Health in Diabetes Brain Magnetic Resonance Imaging Research Group
Źródło :
Journal of the American Geriatrics Society [J Am Geriatr Soc] 2018 Jan; Vol. 66 (1), pp. 120-126. Date of Electronic Publication: 2017 Oct 30.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Behavior Therapy*
Life Style*
Cerebrovascular Circulation/*physiology
Diabetes Mellitus, Type 2/*complications
Obesity/*therapy
Weight Loss/*physiology
Aged ; Cognition/physiology ; Exercise/physiology ; Female ; Humans ; Male ; Middle Aged ; Patient Education as Topic/methods
Czasopismo naukowe
Tytuł :
The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial.
Autorzy :
Johnson KC; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Bray GA; Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.
Cheskin LJ; Johns Hopkins University, Baltimore, MD, USA.
Clark JM; Johns Hopkins University, Baltimore, MD, USA.
Egan CM; Weight Control and Diabetes Research Center, Providence, RI, USA.
Foreyt JP; Baylor College of Medicine, Houston, TX.
Garcia KR; Wake Forest School of Medicine, Wake Forest University, Winston-Salem, NC, USA.
Glasser S; University of Alabama at Birmingham, Birmingham, AL, USA.
Greenway FL; Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.
Gregg EW; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Hazuda HP; The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Hergenroeder A; University of Pittsburgh, Pittsburgh, PA, USA.
Hill JO; University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Horton ES; Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Jakicic JM; University of Pittsburgh, Pittsburgh, PA, USA.
Jeffery RW; University of Minnesota, Minneapolis, MN, USA.
Kahn SE; VA Puget Sound Health Care System, University of Washington, Seattle, WA, USA.
Knowler WC; Southwestern American Indian Center, Phoenix, AZ, USA.
Lewis CE; University of Alabama at Birmingham, Birmingham, AL, USA.
Miller M; University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Montez MG; The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Nathan DM; Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Patricio JL; St. Luke's Roosevelt Hospital Center, Columbia University, New York, NY, USA.
Peters AL; University of Southern California, Los Angeles, CA, USA.
Pi-Sunyer X; Columbia University Medical Center, New York, NY, USA.
Pownall HJ; Houston Methodist Research Institute, Houston, TX, USA.
Reboussin D; Wake Forest School of Medicine, Wake Forest University, Winston-Salem, NC, USA.
Redmon JB; University of Minnesota, Minneapolis, MN, USA.
Steinberg H; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Wadden TA; University of Pennsylvania, Philadelphia, PA, USA.
Wagenknecht LE; Wake Forest School of Medicine, Wake Forest University, Winston-Salem, NC, USA.
Wing RR; The Miriam Hospital/Brown Medical School, Brown University, Providence, RI, USA.
Womack CR; Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Yanovski SZ; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Zhang P; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Schwartz AV; University of California, San Francisco, San Francisco, CA, USA.
Pokaż więcej
Corporate Authors :
Look AHEAD Study Group
Źródło :
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2017 Nov; Vol. 32 (11), pp. 2278-2287. Date of Electronic Publication: 2017 Jul 28.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Weight Loss*
Diabetes Mellitus, Type 2/*epidemiology
Fractures, Bone/*epidemiology
Female ; Humans ; Incidence ; Male ; Middle Aged ; Proportional Hazards Models ; Risk Factors
Czasopismo naukowe
Tytuł :
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
Autorzy :
Aroda VR; MedStar Health Research Institute, Hyattsville, MD, USA. .; Division of Endocrinology, Diabetes, and Metabolism, Georgetown University School of Medicine, Washington, DC, USA. .; The Biostatistics Center, The George Washington University, 6110 Executive Boulevard, Suite 750, Rockville, MD, 20852, USA. .
Knowler WC; Diabetes Epidemiology and Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA.
Crandall JP; Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, New York, NY, USA.
Perreault L; Division of Endocrinology, Metabolism and Diabetes, School of Medicine, University of Colorado Denver, Denver, CO, USA.
Edelstein SL; The Biostatistics Center, The George Washington University, 6110 Executive Boulevard, Suite 750, Rockville, MD, 20852, USA.
Jeffries SL; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Molitch ME; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Pi-Sunyer X; Columbia University Medical Center, New York, NY, USA.
Darwin C; University of California, Los Angeles Medical Center, Los Angeles, CA, USA.
Heckman-Stoddard BM; Division on Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Temprosa M; The Biostatistics Center, The George Washington University, 6110 Executive Boulevard, Suite 750, Rockville, MD, 20852, USA.
Kahn SE; VA Puget Sound Health Care System, Seattle, WA, USA.; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, USA.
Nathan DM; Department of Medicine, Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Corporate Authors :
Diabetes Prevention Program Research Group
Źródło :
Diabetologia [Diabetologia] 2017 Sep; Vol. 60 (9), pp. 1601-1611. Date of Electronic Publication: 2017 Aug 02.
Typ publikacji :
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Diabetes Mellitus, Type 2/*prevention & control
Humans ; Hypoglycemic Agents/therapeutic use ; Metformin/therapeutic use ; Prediabetic State/prevention & control
Czasopismo naukowe
Tytuł :
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
Autorzy :
le Roux CW; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Ireland; Investigative Science, Imperial College London, London, UK. Electronic address: .
Astrup A; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Fujioka K; Division of Endocrinology, Department of Nutrition and Metabolic Research, Scripps Clinic, La Jolla, CA, USA.
Greenway F; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, CA, USA.
Lau DCW; Departments of Medicine and Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.
Van Gaal L; Department of Endocrinology, Diabetology and Metabolic Diseases, Antwerp University Hospital, Antwerp, Belgium.
Ortiz RV; Departamento Endocrinología, Instituto Mexicano del Seguro Social, Ciudad Madero, México.
Wilding JPH; Department of Obesity and Endocrinology, University of Liverpool, Liverpool, UK.
Skjøth TV; Novo Nordisk A/S, Soeborg, Denmark.
Manning LS; Novo Nordisk A/S, Soeborg, Denmark.
Pi-Sunyer X; Division of Endocrinology and Obesity Research Center, Columbia University, New York, NY, USA.
Pokaż więcej
Corporate Authors :
SCALE Obesity Prediabetes NN8022-1839 Study Group
Źródło :
Lancet (London, England) [Lancet] 2017 Apr 08; Vol. 389 (10077), pp. 1399-1409. Date of Electronic Publication: 2017 Feb 23.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Body Weight/*drug effects
Diabetes Mellitus, Type 2/*drug therapy
Liraglutide/*pharmacology
Prediabetic State/*diagnosis
Adult ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Body Mass Index ; Diabetes Mellitus, Type 2/diagnosis ; Double-Blind Method ; Female ; Glucagon-Like Peptide 1/analogs & derivatives ; Glucagon-Like Peptide 1/pharmacology ; Glucagon-Like Peptide-1 Receptor/administration & dosage ; Glucagon-Like Peptide-1 Receptor/agonists ; Humans ; Hypoglycemic Agents/therapeutic use ; Incretins/therapeutic use ; Injections, Subcutaneous ; Liraglutide/administration & dosage ; Liraglutide/adverse effects ; Male ; Middle Aged ; Obesity/complications ; Obesity/drug therapy ; Obesity/epidemiology ; Placebos/administration & dosage ; Placebos/pharmacology ; Prediabetic State/complications ; Prediabetic State/prevention & control ; Risk Reduction Behavior ; Treatment Outcome ; Weight Loss/drug effects
Czasopismo naukowe
Tytuł :
Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects.
Autorzy :
Bays H; a Louisville Metabolic and Atherosclerosis Research Center , Louisville , KY , USA.
Pi-Sunyer X; b New York Obesity Research Center, Columbia University , New York , NY , USA.
Hemmingsson JU; c Capio St Goran's Hospital/Karolinska Institutet , Stockholm , Sweden.
Claudius B; d Novo Nordisk A/S , Søborg , Denmark.
Jensen CB; d Novo Nordisk A/S , Søborg , Denmark.
Van Gaal L; e Department of Endocrinology, Diabetology and Metabolism, Faculty of Medicine , Antwerp University Hospital , Edegem , Belgium.
Pokaż więcej
Źródło :
Current medical research and opinion [Curr Med Res Opin] 2017 Feb; Vol. 33 (2), pp. 225-229. Date of Electronic Publication: 2016 Nov 06.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*therapeutic use
Liraglutide/*therapeutic use
Weight Loss/*drug effects
Adult ; Aged ; Blood Glucose/drug effects ; Blood Pressure ; Body Weight/drug effects ; Double-Blind Method ; Female ; Glycated Hemoglobin A/drug effects ; Humans ; Male ; Middle Aged ; Quality of Life ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis.
Autorzy :
le Roux C; Diabetes Complications Research Centre, Conway Institute of Biomolecular and Biomedical Research, School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland.
Aroda V
Hemmingsson J
Cancino AP
Christensen R
Pi-Sunyer X
Pokaż więcej
Źródło :
Obesity facts [Obes Facts] 2017; Vol. 10 (6), pp. 531-544. Date of Electronic Publication: 2017 Nov 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Body Mass Index*
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*administration & dosage
Liraglutide/*administration & dosage
Obesity/*complications
Adult ; Diabetes Mellitus, Type 2/etiology ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Weight Loss/drug effects
Czasopismo naukowe
Tytuł :
Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients.
Autorzy :
Gallagher D; New York Obesity Nutrition Research Center and .; Institute of Human Nutrition and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Kelley DE; Obesity and Nutrition Research Center, University of Pittsburgh, Pittsburgh, PA.
Thornton J; New York Obesity Nutrition Research Center and.
Boxt L; Department of Radiology, St. Luke's Hospital, New York, NY.
Pi-Sunyer X; New York Obesity Nutrition Research Center and.; Institute of Human Nutrition and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Lipkin E; Division of Metabolism, University of Washington, Seattle, WA; and.
Nyenwe E; Division of Endocrinology Diabetes and Metabolism, University of Tennessee, Martin, TN.
Janumala I; New York Obesity Nutrition Research Center and.
Heshka S; New York Obesity Nutrition Research Center and.; Institute of Human Nutrition and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Pokaż więcej
Corporate Authors :
MRI Ancillary Study Group of the Look AHEAD Research Group
Źródło :
The American journal of clinical nutrition [Am J Clin Nutr] 2017 Jan; Vol. 105 (1), pp. 78-84. Date of Electronic Publication: 2016 Nov 23.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Kidney*/metabolism
Liver*/metabolism
Muscle, Skeletal*/metabolism
Spleen*/metabolism
Diabetes Mellitus, Type 2/*therapy
Obesity/*therapy
Weight Loss/*physiology
Aged ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/metabolism ; Diet, Reducing ; Exercise ; Female ; Heart ; Humans ; Life Style ; Male ; Middle Aged ; Myocardium/metabolism ; Obesity/complications ; Obesity/metabolism ; Organ Size ; Overweight ; Pancreas/metabolism
Czasopismo naukowe
Tytuł :
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
Autorzy :
Gregg EW
Jakicic JM
Blackburn G
Bloomquist P
Bray GA
Clark JM
Coday M
Curtis JM
Egan C
Evans M
Foreyt J
Foster G
Hazuda HP
Hill JO
Horton ES
Hubbard VS
Jeffery RW
Johnson KC
Kitabchi AE
Knowler WC
Kriska A
Lang W
Lewis CE
Montez MG
Nathan DM
Neiberg RH
Patricio J
Peters A
Pi-Sunyer X
Pownall H
Redmon B
Regensteiner J
Rejeski J
Ribisl PM
Safford M
Stewart K
Trence D
Wadden TA
Wing RR
Yanovski SZ
Pokaż więcej
Corporate Authors :
Look AHEAD Research Group
Źródło :
The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2016 Nov; Vol. 4 (11), pp. 913-921. Date of Electronic Publication: 2016 Aug 30.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Physical Fitness*
Weight Loss*
Cardiovascular Diseases/*prevention & control
Diabetes Mellitus, Type 2/*complications
Obesity/*complications
Aged ; Cardiovascular Diseases/etiology ; Cohort Studies ; Disease Management ; Female ; Health Education ; Humans ; Life Style ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders.
Autorzy :
Pi-Sunyer X; a Division of Endocrinology , Columbia University Medical Center , New York , NY , USA.
Shanahan W; b Formerly of the division of Preclinical and Clinical Drug Development , Arena Pharmaceuticals, Inc ., San Diego , CA , USA.
Fain R; c Formerly of the Global Neuroscience Business Unit, Eisai Inc ., Woodcliff Lake , NJ , USA.
Ma T; c Formerly of the Global Neuroscience Business Unit, Eisai Inc ., Woodcliff Lake , NJ , USA.
Garvey WT; d Department of Nutrition Sciences , University of Alabama at Birmingham, and the Birmingham VA Medical Center , Birmingham , AL , USA.
Pokaż więcej
Źródło :
Postgraduate medicine [Postgrad Med] 2016 Aug; Vol. 128 (6), pp. 591-7. Date of Electronic Publication: 2016 Jul 18.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Benzazepines/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Overweight/*drug therapy
Serotonin Receptor Agonists/*therapeutic use
Adolescent ; Adult ; Aged ; Blood Glucose ; Body Mass Index ; Continental Population Groups ; Counseling ; Diet ; Double-Blind Method ; Exercise ; Female ; Glycated Hemoglobin A ; Humans ; Life Style ; Male ; Middle Aged ; Obesity/therapy ; Overweight/therapy ; Weight Loss/drug effects ; Young Adult
Czasopismo naukowe
Tytuł :
Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials.
Autorzy :
Ard J; Wake Forest School of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Cannon A; Endocrine Metabolic Associates, Philadelphia, PA, USA.
Lewis CE; Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Lofton H; New York University School of Medicine, New York, NY, USA.
Vang Skjøth T; Novo Nordisk A/S, Søborg, Denmark.
Stevenin B; Novo Nordisk Inc, Plainsboro, NJ, USA.
Pi-Sunyer X; Columbia University, New York, NY, USA.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2016 Apr; Vol. 18 (4), pp. 430-5. Date of Electronic Publication: 2016 Feb 11.
Typ publikacji :
Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Obesity Agents/*therapeutic use
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*therapeutic use
Liraglutide/*therapeutic use
Obesity/*drug therapy
Overweight/*drug therapy
Prediabetic State/*drug therapy
Adult ; African Continental Ancestry Group ; Anti-Obesity Agents/administration & dosage ; Anti-Obesity Agents/adverse effects ; Asian Continental Ancestry Group ; Body Mass Index ; Combined Modality Therapy/adverse effects ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/ethnology ; Diet, Reducing/ethnology ; Double-Blind Method ; European Continental Ancestry Group ; Exercise ; Female ; Glycated Hemoglobin A/analysis ; Humans ; Hyperglycemia/ethnology ; Hyperglycemia/prevention & control ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Liraglutide/administration & dosage ; Liraglutide/adverse effects ; Male ; Obesity/complications ; Obesity/ethnology ; Obesity/therapy ; Overweight/complications ; Overweight/ethnology ; Overweight/therapy ; Prediabetic State/blood ; Prediabetic State/complications ; Prediabetic State/ethnology ; Quality of Life ; Weight Loss/drug effects ; Weight Loss/ethnology
Czasopismo naukowe
Tytuł :
Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
Autorzy :
Kim C; Departments of Medicine and Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.
Christophi CA; Biostatistics Center, George Washington University, Rockville, MD, USA.
Goldberg RB; Department of Medicine, University of Miami, Miami, FL, USA.
Perreault L; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Dabelea D; Department of Preventive Medicine and Biometrics, Colorado School of Public Health, Aurora, CO, USA.
Marcovina SM; Department of Medicine, University of Washington, Seattle, WA, USA.
Pi-Sunyer X; Division of Endocrinology, Columbia University Medical Center, New York City, NY, USA.
Barrett-Connor E; Department of Family and Preventive Medicine, University of California, San Diego, CA, USA.
Pokaż więcej
Źródło :
Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2016 Jan; Vol. 33 (1), pp. 32-8. Date of Electronic Publication: 2015 May 29.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Adiponectin/*blood
C-Reactive Protein/*analysis
Diabetes Mellitus, Type 2/*etiology
Diabetes, Gestational/*physiopathology
Glucose Intolerance/*blood
Overweight/*therapy
Tissue Plasminogen Activator/*blood
Adult ; Biomarkers/blood ; Body Mass Index ; Cohort Studies ; Combined Modality Therapy ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/prevention & control ; Diet, Reducing ; Female ; Fibrinogen/analysis ; Glucose Intolerance/complications ; Glucose Intolerance/etiology ; Glucose Intolerance/therapy ; Humans ; Hypoglycemic Agents/therapeutic use ; Life Style ; Middle Aged ; Motor Activity ; Overweight/complications ; Pregnancy ; Risk ; United States/epidemiology ; Weight Loss
Czasopismo naukowe
Tytuł :
Weight change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later.
Autorzy :
Unick JL; Weight Control and Diabetes Research Center, Miriam Hospital and Brown Medical School, Providence, Rhode Island, USA.
Neiberg RH; Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Hogan PE; Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Cheskin LJ; Department of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, and the Global Obesity Prevention Center at Johns Hopkins, Baltimore, Maryland, USA.
Dutton GR; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jeffery R; University of Minnesota, Minneapolis, Minnesota, USA.
Nelson JA; Southwest American Indian Center, Phoenix, Arizona, USA.
Pi-Sunyer X; Columbia University Medical Center, New York, New York, USA.
West DS; Arnold School of Public Health at the University of South Carolina, Columbia, South Carolina, USA.
Wing RR; Weight Control and Diabetes Research Center, Miriam Hospital and Brown Medical School, Providence, Rhode Island, USA.
Pokaż więcej
Corporate Authors :
Look AHEAD Research Group
Źródło :
Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2015 Jul; Vol. 23 (7), pp. 1353-6.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Behavior Therapy*
Life Style*
Weight Loss*
Diabetes Mellitus, Type 2/*complications
Obesity/*therapy
Aged ; Body Weight ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Obesity/complications ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies